GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Clinical trials for GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New syringe design tested for eye disease treatment
Disease control CompletedThis study tested whether a prefilled syringe makes it safer and easier to give pegcetacoplan injections for geographic atrophy, a form of advanced age-related macular degeneration that causes vision loss. Forty-four adults aged 60 and older received the injection in one eye. The…
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug shows promise in slowing vision loss from dry macular degeneration
Disease control CompletedThis study looked at the long-term safety and effectiveness of a drug called pegcetacoplan for people with geographic atrophy, a late stage of dry age-related macular degeneration that causes vision loss. About 792 participants who had already been in earlier studies received the…
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Scientists track vision loss in dry macular degeneration
Knowledge-focused CompletedThis study looked at how vision gets worse over time in people with geographic atrophy, an advanced form of dry age-related macular degeneration. Researchers used past medical records and eye scans from 60 patients to see which changes in the retina are linked to faster vision lo…
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Sponsor: IRCCS Ospedale San Raffaele • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC